HRT Financial’s Gilead Sciences GILD Stock Holding History

HRT Financial’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.9M	Buy	214,500 +185,800	+647%	+$26M	0.07%	229
2025 Q4	$3.52M	Buy	+28,700	New	+$3.49M	0.01%	962
2025 Q3	–	Sell	-40,600	Closed	-$4.5M	–	3154
2025 Q2	$4.5M	Buy	40,600 +27,900	+220%	+$2.97M	0.02%	578
2025 Q1	$1.42M	Buy	+12,700	New	+$1.31M	0.01%	963
2021 Q2	–	Sell	-18,100	Closed	-$1.17M	–	3084
2021 Q1	$1.17M	Buy	+18,100	New	+$1.17M	0.01%	979
2020 Q2	–	Sell	-12,300	Closed	-$919K	–	1615
2020 Q1	$919K	Buy	+12,300	New	+$850K	0.06%	266

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HRT Financial's GILD Position: Q1 2026 in Review

HRT Financial opened a new position in Gilead Sciences (GILD) in Q1 2026: 270,699 shares worth $37.7M. The stake represents 0.09% of the portfolio and ranks #179 among its holdings. This is a return to the name: HRT Financial previously reported a position in GILD as recently as Q3 2025.

HRT Financial first reported a position in GILD in Q3 2015 and has held it in 14 quarters since. The position peaked at $147M in Q1 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

HRT Financial held 270,699 shares of Gilead Sciences worth $37.7M as of Q1 2026.
Gilead Sciences was a new HRT Financial position in Q1 2026.
Gilead Sciences made up 0.09% of HRT Financial's portfolio in Q1 2026, its #179 holding.
HRT Financial first reported a position in Gilead Sciences in Q3 2015 and has held it in 14 quarters since.
HRT Financial's Gilead Sciences position peaked at $147M in Q1 2025.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.